SEARCH

SEARCH BY CITATION

References

  • 1
    Mandell SM, Krowka MJ. National database for hepatopulmonary syndrome and portopulmonary hypertension in liver transplant candidates/recipients. Anesthesiology 1997; 87: 450451.
  • 2
    Krowka MJ, Porayko MK, Pleval DJ, Pappas SC, Steers JL, Krom RAF, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation. Mayo Clin Proc 1997; 72: 4453.
  • 3
    Egawa H, Hasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, Kiuchi T, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999; 67: 712717.
  • 4
    Taillé C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand T, Ichai P, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 200; 75: 14821489.
  • 5
    Ramsay MAE, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997; 3: 494500.
  • 6
    Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RAF. Pulmonary hemodynamics and perioperative cardiopulmonary mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443450.
  • 7
    Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients undergoing liver transplantation for hepatopulmonary syndrome. Hepatology 2003; 37: 192119.
  • 8
    Starkel P, Vera A, Gunson B, Mutimer D. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 2002; 8: 382388.
  • 9
    Swanson KL, Wiesner RH, Krowka MJ. Long-term survival in hepatopulmonary syndrome. Chest 2002; 144: 250S251S.
  • 10
    Krowka MJ, Frantz RF, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999; 30: 641648.
  • 11
    Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. J Am Coll Cardiol 2002; 40: 780788.
  • 12
    Swanson KL, McGoon MD, Krowka MJ. Survival in portopulmonary hypertension with the use of intravenous epoprostenol. Am J Respir Crit Care Med 2003; 167: A683.
  • 13
    Alexander J, Greenough A, Baker A, Rela M, Heaton N, Potter D. Nitric oxide treatment of severe hypoxemia after liver transplantation in hepatopulmonary syndrome: case report. Liver Transpl Surg 1997; 3: 5455.
  • 14
    Durand P, Baujard C, Grosse AL, Gomola A, Debray D, Dousset B, Devictor D. Reversal of hypoxemia by inhaled nitric oxide in children with severe hepatopulmonary syndrome, type 1, during and after liver transplantation. Transplantation 1998; 65: 437439.
  • 15
    Meyers C, Low L, Kaufman L, Druger G, Wong LL. Trendelenburg positioning and continuous lateral rotation improve oxygenation in hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 1998; 4: 510512.
  • 16
    Third World Symposium on Pulmonary Artery Hypertension, Venice, Italy 2004. J Am Coll Cardiol (in press).
  • 17
    Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Accuracy of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplant candidates. Liver Transpl 2000; 6: 453458.